Context Therapeutics (CNTX) Earnings Date, Estimates & Call Transcripts $0.23 -0.01 (-2.17%) Closing price 10/27/2026 04:00 PM EasternExtended Trading$0.24 +0.01 (+2.68%) As of 10/27/2026 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings Context Therapeutics Earnings Summary Context Therapeutics announced Q2 2026 earnings on August 5, 2026, reporting an EPS of -$0.15, which missed the consensus estimate of -$0.09 by $0.06. With a trailing EPS of -$0.48, Context Therapeutics' earnings are expected to grow next year, from ($0.45) to ($0.42) per share. Upcoming Q3 Earnings DateNov. 4Before Market OpensEstimatedConsensus EPS (Aug. 5) -$0.09 Actual EPS (Aug. 5) -$0.15 Missed By -$0.06 Q2 2026 Earnings ResourcesQ2 2026 Earnings Report Press Release (8-K) Quarterly Report (10-Q)SEC FilingCNTX Upcoming EarningsContext Therapeutics' Q3 2026 earnings is estimated for Wednesday, November 4, 2026, based on past reporting schedules, with a conference call scheduled on Thursday, November 5, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Context Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Context Therapeutics and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataCNTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Context Therapeutics Upcoming Earnings ConsensusReport DateNovember 4, 2026Consensus EPS Estimate-$0.09Context Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20263-$0.14-$0.10-$0.13Q2 20263-$0.10-$0.09-$0.10Q3 20263-$0.10-$0.07-$0.08Q4 20263-$0.13-$0.08-$0.10FY 202612-$0.47-$0.34-$0.40 Context Therapeutics Earnings History by Quarter 10/28/2024 - 10/28/2026 Report Date Report Date From Report Date To 3M6MYTD1Y2Y3Y5Y10Y More filters Fewer filters Done 0 Results Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2026(Estimated)--$0.09------8/5/2026Q2 2026-$0.0921-$0.15 -$0.0579-$0.15--5/6/2026Q1 2026-$0.12-$0.09+$0.03-$0.09--3/23/2026Q4 2025-$0.11-$0.14 -$0.03-$0.14--11/5/2025Q3 2025-$0.09-$0.10 -$0.01-$0.10--8/6/2025Q2 2025-$0.06-$0.09 -$0.03-$0.09--5/14/2025Q1 2025-$0.05-$0.05--$0.05--3/20/2025Q4 2024-$0.05-$0.04+$0.01---11/6/2024--$0.11-$0.22 -$0.11-$0.22-- Context Therapeutics Earnings - Frequently Asked Questions When is Context Therapeutics' earnings date? Context Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2026 based off last year's report dates. Learn more on CNTX's earnings history. Did Context Therapeutics beat their earnings estimates last quarter? In the previous quarter, Context Therapeutics (NASDAQ:CNTX) missed the analysts' consensus estimate of ($0.09) by $0.06 with a reported earnings per share (EPS) of ($0.15). Learn more on analysts' earnings estimate vs. CNTX's actual earnings. How can I view Context Therapeutics' earnings report? Context Therapeutics' earnings report can be found in their filing with the SEC. View SEC filing What is Context Therapeutics' EPS forecast for next year? Context Therapeutics' earnings are expected to grow from ($0.45) per share to ($0.42) per share in the next year. More Earnings Resources from MarketBeat Related Companies EQ Earnings Results RLYB Earnings Results CRBP Earnings Results SERA Earnings Results ACRV Earnings Results PMN Earnings Results PMVP Earnings Results LUCD Earnings Results CRDF Earnings Results OKYO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Apple's Foldable iPhone Sold Out in Minutes, But Wall Street Has QuestionsCoca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest StrengthWhirlpool's Stock Collapse Raises a Bigger Question About Its Recovery PotentialAnalysts Turn Bullish on Meta Platforms Despite Post-Earnings FallLockheed Martin's F-35 Deal Could Change How Wall Street Values the StockIntel's $155 Price Target Raises a Bigger Question About Its Turnaround PotentialMerck and Moderna's Cancer Vaccine Worked—Who Gets Paid? Earnings data for NASDAQ:CNTX is sourced from Fiscal.ai, with the most recent quarter reported on 8/5/2026. New results are added as companies report their earnings. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Context Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Context Therapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
